What was the main purpose of this 8-K filing by WellPoint, Inc.?

The main purpose of this 8-K filing was to publicly communicate WellPoint's reaffirmed net income guidance for the full fiscal year 2012, projecting earnings per share to be in the range of $7.30 to $7.40. This information was shared with securities analysts and investors during meetings held in September 2012.

What are the key risks and uncertainties that WellPoint highlighted in this filing?

WellPoint highlighted several risks and uncertainties, including the impact of the Patient Protection and Affordable Care Act, fluctuations in healthcare costs and utilization, challenges in securing adequate premium rates, integration of the Amerigroup Corporation acquisition, competitive pricing, risks related to government programs like Medicare and Medicaid, potential downgrades in financial strength ratings, litigation, and general economic conditions.

Is the information in this 8-K considered 'filed' for legal purposes?

No, the filing explicitly states that the information furnished in this report shall not be deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be incorporated by reference into any filings under the Securities Act of 1933. This means it's primarily for disclosure and informational purposes, not subject to the same liabilities as filed documents.

Does this filing announce any new business developments or acquisitions?

No, this 8-K filing does not announce any new material business developments or acquisitions. Its primary focus is on reaffirming existing financial guidance for the full year 2012 and reiterating the company's risk factors. The acquisition of Amerigroup Corporation is mentioned in the context of ongoing integration risks.

ELV 8-K: Regulation FD — Sep 10, 2012

Summary

Elevance Health, Inc. (then WellPoint, Inc.) filed this Form 8-K on September 10, 2012, to disclose information regarding upcoming meetings with securities analysts and investors. The primary purpose of these communications was to reaffirm the company's net income guidance for the full year 2012. Management projected that the company's net income per share would fall within the range of $7.30 to $7.40. This filing also included a standard safe harbor statement under the Private Securities Litigation Reform Act of 1995, highlighting that forward-looking statements made by the company are subject to various risks and uncertainties. These risks encompass regulatory changes (including the Affordable Care Act), healthcare cost trends, acquisition integration challenges (specifically mentioning Amerigroup Corporation), competitive pressures, and operational risks. Investors should note that this 8-K primarily served as an update to financial guidance and a reiteration of risk factors rather than the announcement of a material event.

Key Highlights

1WellPoint reaffirmed its full-year 2012 net income guidance, projecting earnings per share between $7.30 and $7.40.
2The reaffirmation of guidance was communicated during meetings with securities analysts and investors scheduled between September 10 and September 21, 2012.
3The filing includes a comprehensive safe harbor statement for forward-looking statements, indicating potential risks and uncertainties that could affect future results.
4Key risks mentioned include regulatory changes (Affordable Care Act), healthcare cost trends, integration of acquisitions (Amerigroup Corporation), and competitive pressures.
5The company explicitly stated that the information furnished in this report is not deemed 'filed' for Section 18 purposes and should not be incorporated by reference into other filings.
6The report signifies routine investor relations activity and financial guidance updates, not the disclosure of a new material event.
7The company name at the time of filing was WellPoint, Inc., later rebranded as Elevance Health.

Elevance Health, Inc. 8-K Report, Regulation FD Disclosure (Sep 10, 2012)

Summary

Key Highlights

Frequently Asked Questions